taxonomy (1)
protein (1)
source (5)
structure (16)
composition (69)
disease (6)
reference (13)
site (5)
peptide (16)
- Homo sapiens (Human)
Taxonomy
- Hemopexin / Homo sapiens P02790
Protein
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- Cerebrospinal Fluid Secretion (GO_0033326)
Source
- N-Linked / Complex / Structure 2011
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 3041
- N-Linked / Complex / Structure 3507
- N-Linked / Complex / Structure 644
- N-Linked / Complex / Structure 3534
- N-Linked / Complex / Structure 473
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 3232
- N-Linked / Complex / Structure 572
- N-Linked / Complex / Structure 720
- N-Linked / Complex / Structure 3126
- N-Linked / Complex / Structure 2391
- N-Linked / Complex / Structure 3627
- N-Linked / Complex / Structure 1991
- N-Linked / Undefined core / NeuAc(??-?)Hex(??-?)HexNAc(??-?)Hex(??-?)[Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)HexNAc
Reported structure
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
- Hex:3 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2452.2713 )
- Hex:3 HexNAc:6 dHex:3 (avg mass : 2162.0415 )
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:3 HexNAc:9 dHex:1 (avg mass : 2479.3405 )
- Hex:4 dHex:1 (avg mass : 812.7279 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 (avg mass : 2281.0751 )
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2266.1038 )
- Hex:4 HexNAc:5 dHex:3 (avg mass : 2120.9889 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:1 NeuGc:1 (avg mass : 2240.0225 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2428.2462 )
- Hex:5 HexNAc:6 (avg mass : 2047.8973 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:5 HexNAc:8 (avg mass : 2454.2873 )
- Hex:5 HexNAc:8 dHex:1 (avg mass : 2600.4303 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 (avg mass : 3172.9044 )
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:6 HexNAc:8 dHex:2 (avg mass : 2908.7157 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2897.6459 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 NeuAc:1 (avg mass : 2663.44 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:2 (avg mass : 2664.4681 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:3 (avg mass : 3538.2418 )
- Hex:7 HexNAc:6 dHex:3 (avg mass : 2810.6111 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:8 HexNAc:7 NeuAc:1 (avg mass : 3028.7774 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
- Carcinoma (DOID:305)
- Carcinoma, Hepatocellular (DOID:684)
- Esophageal cancer (DOID:5041)
- Oral squamous cell carcinoma (DOID:0050866)
- Prostate cancer (DOID:10283)
Disease
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Tongue Cancer Patients Can be Distinguished from Healthy Controls by Specific N-Glycopeptides Found in Serum. (2018 - Mayank Saraswat, Antti Mäkitie, Tiialotta Tohmola, Amy Dickinson, Shruti Saraswat, Sakari Joenväärä, Suvi Renkonen) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins (2014 - Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R.) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Glycomic analysis of high density lipoprotein shows a highly sialylated particle (2014 - Huang J1, Lee H, Zivkovic AM, Smilowitz JT, Rivera N, German JB, Lebrilla CB) / Status : Reviewed
- LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins (2013 - Halim A, Rüetschi U, Larson G, Nilsson J) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
Reference
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- ATTLDDNGTMLFFKGE (16aa)
- DDNGTMLFFK (10aa)
- SFDATTLDDNGTMLFFK (17aa)
- TLDDNGTMLFFK (12aa)
- SWPAVGNCSSAL (12aa)
- SWPAVGNC (8aa)
- SWPAVGNCSSAIR (13aa)
- PAVGNCSSALR (11aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNV (8aa)
- ALPQPQNVTSLLGCTH (16aa)
- ALPQPQNVTSLLGC (14aa)
- ALPQPQNVTSLLGCT (15aa)
- NVTSLLGCTH (10aa)
- AIPQPQNVTSIIGCTH (16aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1479.3649)
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1641.5073)
- Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins (2014 - Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R.) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1787.6503)
- Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins (2014 - Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R.) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1932.7652)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2006.8447)
- Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins (2014 - Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R.) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2152.9877)
- Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins (2014 - Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R.) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2299.1307)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2370.1661)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2372.1821)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2518.3251)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2589.3605)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2664.4681)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2810.6111)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
-
- N-Linked / Undefined core (avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- Hemopexin / Homo sapiens
-
- Hex:4 dHex:1 / N-Linked (avg mass : 812.7279)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- PAVGNCSSALR (11aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- ATTLDDNGTMLFFKGE (16aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- ATTLDDNGTMLFFKGE (16aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked (avg mass : 1625.5079)
- Blood Plasma (UBERON_0001969)
- Hemopexin / Homo sapiens
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- ATTLDDNGTMLFFKGE (16aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Structure 3041
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- ATTLDDNGTMLFFKGE (16aa)
-
- Hex:6 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1891.7126)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Hemopexin / Homo sapiens
- ATTLDDNGTMLFFKGE (16aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSALR (13aa)
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 1916.7658)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:3 HexNAc:7 / N-Linked (avg mass : 1926.8075)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- N-Linked / Complex / Structure 3507
- N-Linked / Undefined core / NeuAc(??-?)Hex(??-?)HexNAc(??-?)Hex(??-?)[Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)HexNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- TLDDNGTMLFFK (12aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- NVTSLLGCTH (10aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:4 dHex:2 / N-Linked (avg mass : 1933.7933)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- ALPQPQNVTSLLGCTH (16aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked (avg mass : 1949.7927)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:6 / N-Linked (avg mass : 2047.8973)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:7 HexNAc:4 dHex:1 / N-Linked (avg mass : 2111.9351)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
-
- Hex:4 HexNAc:5 dHex:3 / N-Linked (avg mass : 2120.9889)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:3 HexNAc:6 dHex:3 / N-Linked (avg mass : 2162.0415)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- ALPQPQNVTSLLGCTH (16aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked (avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
-
- Hex:5 HexNAc:6 dHex:1 / N-Linked (avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:6 HexNAc:6 / N-Linked (avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
- SWPAVGNC (8aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- N-Linked / Complex / Structure 473
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Glycomic analysis of high density lipoprotein shows a highly sialylated particle (2014 - Huang J1, Lee H, Zivkovic AM, Smilowitz JT, Rivera N, German JB, Lebrilla CB) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- ATTLDDNGTMLFFKGE (16aa)
- DDNGTMLFFK (10aa)
- SFDATTLDDNGTMLFFK (17aa)
- TLDDNGTMLFFK (12aa)
- SWPAVGNCSSAL (12aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNV (8aa)
- ALPQPQNVTSLLGCTH (16aa)
- ALPQPQNVTSLLGC (14aa)
- NVTSLLGCTH (10aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCT (15aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:4 NeuAc:1 NeuGc:1 / N-Linked (avg mass : 2240.0225)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- SWPAVGNCSSALR (13aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2266.1038)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
-
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 / N-Linked (avg mass : 2281.0751)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:6 HexNAc:6 dHex:1 / N-Linked (avg mass : 2356.1827)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- N-Linked / Complex / Structure 572
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:5 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2428.2462)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2444.2456)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:6 HexNAc:5 dHex:3 / N-Linked (avg mass : 2445.2737)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
-
- Hex:3 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 2452.2713)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- ALPQPQNVTSLLGCTH (16aa)
-
- Hex:5 HexNAc:8 / N-Linked (avg mass : 2454.2873)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- ALPQPQNVTSLLGCTH (16aa)
-
- Hex:3 HexNAc:9 dHex:1 / N-Linked (avg mass : 2479.3405)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- ALPQPQNVTSLLGCTH (16aa)
-
- Hex:7 HexNAc:6 dHex:1 / N-Linked (avg mass : 2518.3251)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 / N-Linked (avg mass : 2590.3886)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:5 HexNAc:8 dHex:1 / N-Linked (avg mass : 2600.4303)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
-
- Hex:7 HexNAc:6 NeuAc:1 / N-Linked (avg mass : 2663.44)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
-
- Hex:7 HexNAc:6 dHex:2 / N-Linked (avg mass : 2664.4681)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:7 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2897.6459)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Hemopexin / Homo sapiens
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:6 HexNAc:8 dHex:2 / N-Linked (avg mass : 2908.7157)
- Blood Serum (UBERON_0001977)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
-
- Hex:8 HexNAc:7 NeuAc:1 / N-Linked (avg mass : 3028.7774)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 / N-Linked (avg mass : 3172.9044)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3229.9564)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- ALPQPQNVTSLLGCTH (16aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:3 / N-Linked (avg mass : 3538.2418)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Hemopexin / Homo sapiens
- SWPAVGNCSSALR (13aa)
-
- Hex:1 HexNAc:1 / O-Linked (avg mass : 383.3527)
- LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins (2013 - Halim A, Rüetschi U, Larson G, Nilsson J) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Hemopexin / Homo sapiens
-
- Hex:1 HexNAc:1 NeuAc:1 / O-Linked (avg mass : 674.6106)
- Blood Plasma (UBERON_0001969)
- Hemopexin / Homo sapiens
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Reported glycosite
Suggested glycosite
Source
Reported glycosite
Suggested glycosite
Source
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Reported glycosite
Suggested glycosite
Source
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Reference
Reported glycosite
Suggested glycosite
Reference
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Reference
Reported glycosite
Suggested glycosite
Reference
Reported glycosite
Suggested glycosite
Disease
Reported glycosite
Suggested glycosite
